1. Home
  2. BIO vs TEM Comparison

BIO vs TEM Comparison

Compare BIO & TEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • TEM
  • Stock Information
  • Founded
  • BIO 1952
  • TEM 2015
  • Country
  • BIO United States
  • TEM United States
  • Employees
  • BIO N/A
  • TEM N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • TEM
  • Sector
  • BIO Industrials
  • TEM
  • Exchange
  • BIO Nasdaq
  • TEM NYSE
  • Market Cap
  • BIO 8.7B
  • TEM 9.3B
  • IPO Year
  • BIO N/A
  • TEM 2024
  • Fundamental
  • Price
  • BIO $320.44
  • TEM $47.49
  • Analyst Decision
  • BIO Buy
  • TEM Strong Buy
  • Analyst Count
  • BIO 4
  • TEM 9
  • Target Price
  • BIO $369.00
  • TEM $45.25
  • AVG Volume (30 Days)
  • BIO 222.4K
  • TEM 1.3M
  • Earning Date
  • BIO 10-24-2024
  • TEM 08-06-2024
  • Dividend Yield
  • BIO N/A
  • TEM N/A
  • EPS Growth
  • BIO N/A
  • TEM N/A
  • EPS
  • BIO N/A
  • TEM N/A
  • Revenue
  • BIO $2,562,604,000.00
  • TEM $595,570,000.00
  • Revenue This Year
  • BIO N/A
  • TEM $32.58
  • Revenue Next Year
  • BIO $4.49
  • TEM $32.44
  • P/E Ratio
  • BIO N/A
  • TEM N/A
  • Revenue Growth
  • BIO N/A
  • TEM 85.73
  • 52 Week Low
  • BIO $261.59
  • TEM $22.89
  • 52 Week High
  • BIO $384.37
  • TEM $77.00
  • Technical
  • Relative Strength Index (RSI)
  • BIO 50.24
  • TEM N/A
  • Support Level
  • BIO $311.04
  • TEM N/A
  • Resistance Level
  • BIO $337.50
  • TEM N/A
  • Average True Range (ATR)
  • BIO 8.18
  • TEM 0.00
  • MACD
  • BIO -1.35
  • TEM 0.00
  • Stochastic Oscillator
  • BIO 43.70
  • TEM 0.00

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About TEM TEMPUS AI INC

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Share on Social Networks: